Skip to main content

DCVC — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

286
Companies
$4.9B
Total invested
$27.4M
Avg. check
49
Industries
Biotechnology 9Artificial Intelligence (AI) 6Therapeutics 5Software 5Health Care 5Machine Learning 5+43 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 286
Zap Energy
September 2024

Zap Energy is developing compact fusion power that doesn't require magnets or lasers.

Clean Energy · Everett$130.0M Series D
Insight Engines
September 2022

Insight Engines provides Making machine data accessible to everyone via natural language processing

Artificial Intelligence (AI) · San Francisco$12.5M Venture - Series Unknown
Novome Biotechnologies
September 2022

Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.

Biopharma · South San Francisco$43.5M Series B
Brimstone
August 2025

Brimstone is a hardware cleantech startup that aims to reduce CO2 emissions through innovative technologies.

Building Material · BerkeleyUndisclosed
Rill Data
August 2022

Rill Data is a simple alternative to complex BI stacks—the fastest, easiest path from data to metrics dashboards.

Analytics · San Francisco$12.0M Seed
Verdant Robotics, Inc.
August 2022

Verdant builds AI-powered Smart Sprayers that weed, thin, fertilize & deliver nutrients at millimeter level.

Agriculture · Hayward$46.5M Series A
Molecular Assemblies
August 2024

Molecular Assemblies is developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products.

Biotechnology · San Diego$4.0M Grant
Plexium
August 2025

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

Biotechnology · San Diego$60.1M Series C
MindRhythm
August 2021

MindRhythm is an evolved neurodiagnostics company discovering and developing unique biometrics to solve unmet needs in medicine.

Health Diagnostics · Cupertino$5.0M Seed
Alchemab Therapeutics
July 2026

Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.

Biotechnology · London$33.6M Series A
MycoWorks
July 2024

MycoWorks is a biotechnology company that offers non-plastic and non-animal materials to the market.

Biotechnology · EmeryvilleSeries D
Evolv Technology
July 2025

Evolv Technology an AI-enabled touchless security screening system that uses digital sensors and artificial intelligence to detect threats.

Artificial Intelligence (AI) · Waltham$75.0M Post-IPO Debt
Semantic Health
July 2023

AI-Powered Concurrent Coding and Auditing Platform

Health Care · TorontoDebt Financing
Estes Energy
July 2025

Estes Energy is a California-based startup developing advanced, U.S.-made, chemistry-agnostic battery packs for mobility and industry.

Chemical · San Francisco$11.0M Seed
Pivot Bio
July 2021

Pivot Bio is an agricultural tech company improving the microbiome by taking nitrogen from the air and making it available for plants.

Agriculture · Berkeley$430.0M Series D
Auron Therapeutics
July 2025

Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.

Biotechnology · NewtonVenture - Series Unknown
TigerGraph
July 2025

TigerGraph supports advanced analytics and machine learning platforms through its distributed native graph database.

Analytics · Redwood CityVenture - Series Unknown
Stemson Therapeutics
July 2021

Stemson Therapeutics is a pre-clinical stage cell therapy company.

Biotechnology · San Diego$15.0M Series A
Sabanto
July 2026

Sabanto provides a Farming-as-a-Service tool that transforms existing tractors into fully autonomous machines.

Agriculture · Chicago$17.0M Series B
Cape Analytics
July 2021

Cape Analytics provides AI and analytics services for properties.

Analytics · Palo Alto$44.0M Series C
Reach
June 2026

Reach is a technology company that builds long-range wireless power networks that deliver scalable and resilient energy infrastructure.

Energy · Redwood CityGrant
NALEJ
June 2024

NALEJ is an AI-powered edge computing and infrastructure management platform.

Artificial Intelligence (AI) · New YorkDebt Financing
Frontier Medicines
June 2024

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

Biopharma · San Francisco$20.0M Series C
Subtle Medical
June 2026

Subtle Medical provides AI-powered medical imaging software that enhances image quality and efficiency.

Artificial Intelligence (AI) · Menlo Park$33.0M Series C

Where DCVC invests

Biotechnology9
Artificial Intelligence (AI)6
Therapeutics5
Software5
Health Care5
Machine Learning5

About DCVC's portfolio

How many companies has DCVC invested in?

DCVC has invested in 286 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does DCVC invest in?

DCVC's top investment sectors include Biotechnology, Artificial Intelligence (AI), Therapeutics, Software, Health Care. The firm invests across 49 different industry categories.

What is DCVC's largest investment?

Among tracked funding rounds, Pivot Bio received $430.0M in a Series D round. DCVC's total known invested capital is $4.9B.

What is the average investment size for DCVC?

DCVC's average investment size is $27.4M across its portfolio of 286 companies.

What are DCVC's most recent investments?

Recent DCVC portfolio additions include Zap Energy, Insight Engines, Novome Biotechnologies, Brimstone, Rill Data. These companies were founded in 2020 or later.

Reach the founders behind these 286 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →